sodium azide - certified quality - wir arbeiten deutsch
Art.-No. 631
Relevant identified uses of the substance: laboratories, food industry, pharmaceuticals, veterinary medicine, laboratories, food industry, pharmaceuticals
Category: Chemical substances, free/ without restriction
Source for organically bonded magnesium, RDA(Mg) 375mg
PU/ SU: 25g, 100g
Chemical composition: C10H6N4O8Mg.2H2O, 99.6%
Other parameters
Gehalt 98.0-101.1%
Magnesium, Mg 7.27%
Havy metals <20ppm
GMO free, produced acc. GMP
Synonyms
Orotan hořečnatý dihydrát, Magnesium orotate dihydrate
Magnesii orotas dihydricus, Magnesiumsalz der Orotsäure (Uracil-6-carbonsäure), Magnesium-uracil-6-carboxylat Dihydrat
INCI ?
IUPAC Magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate, Magnesium bis(2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylate)
Properties
Magnesium orotate dihydrate is white crystalline substance with no odor, no taste; insoluble in water.
Use
Magnesium orotate is used as nutritional supplement.
Pharma: activ pharmaceutical ingredient, API
Magnesium orotate is used as drugs such as angiotensin inhibitor intermediates.
Magnesium orotate is an active ingredient from the group of minerals that is used, among other things, to treat leg cramps, a magnesium deficiency and as a general sedative. It is the magnesium salt of orotic acid. Possible adverse effects include loose stools and diarrhea. Magnesium orotate can affect the absorption of some drugs.
Wadenkrämpfe, Muscle cramps
Magnesiummangel
Als allgemeines Beruhigungsmittel
Als Adjuvans bei Herzinsuffizienz (siehe z.B. bei Stepura & Martynow, 2009) - keine offizielle medizinische Indikation.
Identifiers
CAS 27067-77-2 anhydrous
CAS 34717-03-8 dihydrate
EU 252-167-6
E - not in the directory
Ph.Eur. API, Apo-ident
FEMA ?
HS-No. ?
UN, ADR - is not subject to the regulations
LQ - not determined
MW 334.48 anhydrous/ 370.51 Dihydrate
Safety information GHS/ Hazard identification: none
Storage
in closed container by RT.
minimum shelf life: 2 yars
more Information, Literature
CoA und/oder MSDS gem. VO(EG) Nr. 1907/2006 (REACH) - please request
Food low acc. VO(EU) Nr. 231/2012
Health related information acc. regulation of (EU) No. 432/201 - Magnesium
RDA/ ETD = ADI Acceptable Daily Intake in mg/ kg acc. to the directive 90/496/EWG
European Pharmacopoeia http://www.fptl.ru/biblioteka/farmacop/EP-7.0-2.pdf
Article about the application / quotes:
Wiki:
PubChem #:
Notice:
Disclaimer:
The end user decides on the use of the substance / preparation and assumes full responsibility for it.
Despite careful content control, we assume no liability for the content of external links. The content of the linked pages are the sole responsibility of their operators.
Alternative medicin: no evidence, non-tablet powder
Keywords: orotic acid
Update: 21.01.2024
Art.-No. 631
Magnesium orotate dihydrat pure
Charakteristics: organic substance - Magnesium salt of Orotic acid as dihydrate, not tableted.Relevant identified uses of the substance: laboratories, food industry, pharmaceuticals, veterinary medicine, laboratories, food industry, pharmaceuticals
Category: Chemical substances, free/ without restriction
Source for organically bonded magnesium, RDA(Mg) 375mg
PU/ SU: 25g, 100g
Chemical composition: C10H6N4O8Mg.2H2O, 99.6%
Other parameters
Gehalt 98.0-101.1%
Magnesium, Mg 7.27%
Havy metals <20ppm
GMO free, produced acc. GMP
Synonyms
Orotan hořečnatý dihydrát, Magnesium orotate dihydrate
Magnesii orotas dihydricus, Magnesiumsalz der Orotsäure (Uracil-6-carbonsäure), Magnesium-uracil-6-carboxylat Dihydrat
INCI ?
IUPAC Magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate, Magnesium bis(2,6-dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylate)
Properties
Magnesium orotate dihydrate is white crystalline substance with no odor, no taste; insoluble in water.
Use
Magnesium orotate is used as nutritional supplement.
Pharma: activ pharmaceutical ingredient, API
Magnesium orotate is used as drugs such as angiotensin inhibitor intermediates.
Magnesium orotate is an active ingredient from the group of minerals that is used, among other things, to treat leg cramps, a magnesium deficiency and as a general sedative. It is the magnesium salt of orotic acid. Possible adverse effects include loose stools and diarrhea. Magnesium orotate can affect the absorption of some drugs.
Wadenkrämpfe, Muscle cramps
Magnesiummangel
Als allgemeines Beruhigungsmittel
Als Adjuvans bei Herzinsuffizienz (siehe z.B. bei Stepura & Martynow, 2009) - keine offizielle medizinische Indikation.
Identifiers
CAS 27067-77-2 anhydrous
CAS 34717-03-8 dihydrate
EU 252-167-6
E - not in the directory
Ph.Eur. API, Apo-ident
FEMA ?
HS-No. ?
UN, ADR - is not subject to the regulations
LQ - not determined
MW 334.48 anhydrous/ 370.51 Dihydrate
Safety information GHS/ Hazard identification: none
Storage
in closed container by RT.
minimum shelf life: 2 yars
more Information, Literature
CoA und/oder MSDS gem. VO(EG) Nr. 1907/2006 (REACH) - please request
Food low acc. VO(EU) Nr. 231/2012
Health related information acc. regulation of (EU) No. 432/201 - Magnesium
RDA/ ETD = ADI Acceptable Daily Intake in mg/ kg acc. to the directive 90/496/EWG
European Pharmacopoeia http://www.fptl.ru/biblioteka/farmacop/EP-7.0-2.pdf
Article about the application / quotes:
Wiki:
PubChem #:
Notice:
Disclaimer:
The end user decides on the use of the substance / preparation and assumes full responsibility for it.
Despite careful content control, we assume no liability for the content of external links. The content of the linked pages are the sole responsibility of their operators.
Alternative medicin: no evidence, non-tablet powder
Keywords: orotic acid
Update: 21.01.2024
